Looking for Something?

Levine Cancer Institute

Atrium Health Levine Cancer Institute Awarded Highest Level of Achievement for Excellence in Person-Centered Care by Planetree Awards International

Posted by Paula Takacs Foundation
levine cancer institute building

Levine Cancer Institute is the only cancer center in United States and one of two worldwide to earn this prestigious recognition

CHARLOTTE, N.C., Feb. 15, 2022 – Levine Cancer Institute (LCI) has once again been awarded Gold Certification for Excellence in Person-Centered Care by Planetree International. In 2017, LCI became the first cancer center in the world to earn the top designation for patient-centered cancer care delivery. Since then, LCI has diligently continued to expand their level of commitment to patients. LCI optimizes the patient experience with a focus on the active participation of patients and their families throughout the healthcare process, with an emphasis on partnership, compassion, transparency, inclusion, and quality. This unwavering dedication to patients has led to LCI’s latest recognition by the Planetree International Organization.

The Person-Centered Care Certification® acknowledges the organization’s achievement and innovation in the delivery of person-centered care, with the Gold Certification for Excellence in Person-Centered Care being the highest level of achievement based on evidence and standards. As documented by this international honor, LCI is dedicated to delivering world-class treatment that never overshadows its commitment to the real people, families and lives touched by the care provided by LCI teammates.

“The Planetree award helps us to focus each day on the needs and concerns of our patients and their caregivers,” said Derek Raghavan, MD, president of Atrium Health Levine Cancer Institute. “While we consistently focus on all the medical aspects of care, we don’t neglect the nuances and subtleties that are part of making patients feel safe and among friends. Our Planetree commitment extends to all aspects of our treatment and research and to all parts of our community.”

Read More

Back to Latest news
<< Back to Latest news